I-Comfrey cream iyinhlobo yemvelo eyenziwe evela ku- Symphytum officinale , isitshalo emndenini we-borage. Eyaziwa nangokuthi amafutha e-comfrey, i-salve, noma i-gel, kuthiwa ukunciphisa ukuvuvukala nokunciphisa ubuhlungu lapho kusetshenziswe phezulu (okungukuthi, ngokuqondile esikhumbeni). Abagqugquzeli bathi i-comfrey cream ingaphatha izimo ezihlukahlukene zezempilo kanye nokulimala.
I-Comfrey ukhilimu iqukethe izinto eziningana ezicatshangwa ukuthi zinezakhiwo eziwusizo, kuhlanganise nama-anti-inflammatory compounds kanye ne-allantoin (into ecatshangelwe ukusheshisa ukuphulukiswa kwesilonda ngokugqugquzela ukukhula kwamangqamuzana amasha).
Okwenza Abantu Bisebenzise
I-Comfrey ayisikhilimu isetshenziselwa ukwelashwa kwamakhemikhali okwebuhlungu obuhlungu obuhlungu obukhulu obubhekene nemisipha kanye nezimo ezihlangene, ezifana nobuhlungu obuphansi emuva, i-osteoarthritis, ne-sprains. Ibuye isetshenziswe eminye imithi yezinkinga ezilandelayo:
- I-Bruises
- Ama-Fractures
- Gout
- I-rheumatoid arthritis
- I-Sprains kanye nezinkinga
- Amanxeba
Izinzuzo
Nakhu ukubuka ezinye izihluthulelo ezisemqoka ezinzuzo zezempilo ze-comfrey cream:
1) Ubuhlungu Emuva
I-Comfrey cream ingasiza ekunciphiseni ubuhlungu emuva , iphakamisa isifundo se-2010 esisuka eBritish Journal of Sports Medicine . Ucwaningo lwaluhlanganisa neziguli ezingu-120 ezinezinhlungu eziphezulu eziphansi noma eziphansi, okwakubhekwa kuwo wonke amafutha e-comfrey noma i-placebo izinsuku ezinhlanu. Imiphumela yocwaningo yembula ukuthi ubuhlungu obukhulu buwehla ngamaphesenti angu-95.2 eqenjini elinikezwe amafutha e-comfrey (kuqhathaniswa namaphesenti angu-37.8 eqenjini le-placebo).
2) i-osteoarthritis
I-Comfrey cream ingasiza ukuphatha i-osteoarthritis yamadolo, ngokusho kocwaningo olushicilelwe ePhytomedicine ngo-2007.
Ukuze kuhlolwe, abantu abangu-220 abane-osteoarthritis yamadolo banikezwa amaviki amathathu okwelashwa nge-comfrey amafutha noma i-placebo. Ngokuphela kokucwaninga, labo abasebenzisa amafutha e-comfrey babhekene nokuthuthukiswa okukhulu kakhulu ebuhlungu, ukuhamba, kanye nekhwalithi yokuphila (uma kuqhathaniswa namalungu eqembu le-placebo).
Ukwengeza, isifundo se-2011 eshicilelwe kuyi- Journal of Chiropractic Medicine sathola ukuthi amafutha e-comfrey aphakeme kune-placebo ekunciphiseni ubuhlungu nokuqina nokuqinisa ukusebenza komzimba. Ucwaningo lwabandakanya iziguli ezingama-43 ezine-knee-osteoarthritis kanye nesonto lokuphulukisa isonto eliyisithupha.
Kodwa-ke, isifundo esilandelayo (eshicilelwe ku- Osteoarthritis Cartilage ngo-2012) sathola ubufakazi bokuthi ukhilimu we-comfrey oqoshiwe oqukethe i-comfrey ukhiphe ubuhlungu obunciphise, kodwa awunamthelela emakhenini okuvuvukala noma ukuwa kwe-cartilage ngaphezu kwamasonto angu-12 okwelashwa.
3) i-Ankle Sprains
Ucwaningo oluthile lubonisa ukuthi i-comfrey cream ingaba usizo ekwelapheni kwe-ankle sprains. Ucwaningo olwenziwe ngo-2005 olushicilelwe ePhytomedicine , ngokwesibonelo, abacwaningi bathola ukuthi amafutha e-comfrey angasebenza kahle njengejelisi le-Diclofenac (isidakamizwa esingafuni ukuvimbela isisindo) uma kutholakala ekunciphiseni ubuhlungu obuhlobene ne-ankle-sprain. Lolu cwaningo lwaluhlanganisa iziguli ezingu-164 ezinama-ankle sprains, ngamunye wazo owaphathwa cishe isonto.
4) Ukwelashwa Okulimazayo
I-Comfrey cream ibonisa isithembiso ekwelapheni amanxeba, ngokusho kocwaningo olwenziwe ngo-2012 olwanyatheliswa encwadini ethi German Drug Research . Ucwaningo lwabandakanya izingane ezingu-108 (abaneminyaka engama-3 kuya kweyishumi nambili), ngamunye wabo osanda kuhlushwa.
Abacwaningi banikeze izingane ukuthi zithole ukwelashwa ngekhrimu equkethe ama-10 amaphesenti ama-comfrey akhiphe noma ama-1 amaphesenti ama-comfrey akhiphe.
Kulabo abanikezwa ukhilimu onamazinga aphezulu okukhipha ama-comfrey, izinga lokuphulukisa ngamaphesenti angu-50 lifinyelelwe ezinsukwini ezingu-0.9 ngaphambili (uma kuqhathaniswa nalabo abanikezwa umthamo ophansi we-comfrey). Ngaphezu kwalokho, izingane kanye nabazali bazo kanye nodokotela babhala ukuphumelela kwekhrimu engu-10 ekhulwini njengokukhulu kakhulu kunalokho kwe-1% ye-cream.
Imiphumela Ezingenakwenzeka
I-Comfrey iqukethe ama-alkaloids e-pyrrolizidine, izinto ezingabangela ukulimala kwesibindi, umdlavuza, ngisho nokufa, ngakho akufanele kuthathwe ngomlomo.
Ukuphathwa Kwezokudla Nezidakamizwa (i-FDA) ivimbele imikhiqizo yomlomo ye-comfrey.
Njengoba lezi zinto ezinobuthi zingangena esikhumbeni, kukhona ukukhathazeka ngokuphepha kwe-comfrey cream esetshenziswa esikhumbeni. Ijwayele ukusetshenziselwa imali encane kuphela isikhathi esifushane kakhulu. Ochwepheshe basikisela isikhathi esingaphezu kwezinsuku ezingu-10 kulandelana futhi asingekho amasonto amane kuya kwanguyisithupha ngonyaka njengesiqondiso esijwayelekile, kodwa futhi kuncike ezintweni ezifana nokuqina kwesikhumba.
Uma ucabangela ukusebenzisa ukhilimu, qiniseka ukuthi uthintane nomhlinzeki wakho wezokunakekelwa kwezempilo kuqala ukulinganisa izinzuzo nezindleko nokusebenzisa kuphela ngaphansi kokuphatha kwakhe.
Ungalokothi usebenzise i-comfrey cream esikhumbeni esiphukile noma amanxeba avulekile. Ungayithathi Uma unesifo sesibindi, umdlavuza, noma uthatha noma yimiphi imithi ethinta isibindi. Izingane, abantu asebekhulile, nabesifazane abakhulelwe noma abahlengikazi akufanele basebenzise i-comfrey nganoma yiluphi uhlobo.
I-Takeaway
Ngesikhathi ucwaningo lubonisa ukuthi i-comfrey cream inganikeza izinzuzo zokunciphisa ubuhlungu, ukuhlolwa okukhulu kwemitholampilo kuyadingeka ukuqinisekisa le miphumela. Njengoba kunikezwe ukukhathazeka kokuphepha, kufanele kusetshenziswe kuphela ngaphansi kokuqondiswa komhlinzeki wakho wezempilo.
Isizathu esisodwa sokukhubazeka emhlabeni jikelele, ubuhlungu bomhlane buvame ukuphathwa ngemithi (njengalapho kunciphisa ubuhlungu). Ezinye izindlela zokwelashwa ezingase zenzeke zingasiza ekunciphiseni ubuhlungu. Ngokwesibonelo, ucwaningo lubonisa ukuthi ukugunwa noma ukuthatha i-yoga kungasiza ukunciphisa ubuhlungu nokusiza abantu abanezinkinga emuva noma ezihlangene ukusebenza kalula. Kukhona nobufakazi bokuthi ukhilimu we-capsaicin ukhilimu ungasiza ekunciphiseni ubuhlungu okwesikhashana.
Imithombo
Giannetti BM, Staiger C, uBulitta M, uPredel HG. Ukusebenza nokuphepha kwemifino ye-comfrey kukhishwa amafutha ekuphulukeleni ubuhlungu obukhulu obuphansi noma obuphansi emuva: imiphumela ye-double-blind, randomized, i-placebo elawulwayo, isilingo sezintambo eziningi. I-Br J Sports Med. 2010 Jul; 44 (9): 637-41.
Grube B, Grünwald J, Krug L, Staiger C. Ukusebenza komcibisholo we-comfrey (i-Symphyti offic. I-radix) kukhishwa amafutha lapho ukwelashwa iziguli ezine-osteoarthritis ebuhlungu emadolweni: imiphumela ye-double-blind, randomized, bicenter, placebo- isivivinyo esilawulwayo. I-Phytomedicine. 2007 Jan; 14 (1): 2-10.
Laslett LL, Quinn SJ, uDarian-Smith E, et al. Ukwelapha nge-4Jointz kunciphisa ubuhlungu emadolweni ngaphezu kwamasonto angu-12 yokwelapha ezigulini ezine-osteoarthritis e-clinical: isilingo esilawulwa ngokungahleliwe. I-osteoarthritis. 2012 Nov; 20 (11): 1209-16.
I-Predel HG, i-Giannetti B, i-Koll R, i-Bulitta M, i-Staiger C. Ukusebenza komcibisholo we-comfrey kukhishwa amafutha okuqhathaniswa uma kuqhathaniswa nejeri le-diclofenac ekwelapheni ukuphazamiseka kwe-ankle: imiphumela yomfundi oyimpumputhe, oyimpumputhe, ongenamaphuzu, ocwaningisisiwe. I-Phytomedicine. 2005 Nov; 12 (10): 707-14.
Smith DB, Jacobson BH. Umphumela wokuhlanganiswa kwezimpande ze-comfrey (i-Symphytum officinale L.) kanye nama-tannic acid creams ekwelapheni i-osteoarthritis yamadolo: okulawulwe ngokungahleliwe, okulawulwa kwe-placebo, okubili okuyimpumputhe, okuvivinyelwa ngamaningi. J Chiropr Med. 2011 Sep; 10 (3): 147-56.